<DOC>
	<DOCNO>NCT00863681</DOCNO>
	<brief_summary>Patients complete 12 week treatment PATENT-1 trial ( study number 12934 ) ask participate long term extension study BAY63-2521 .</brief_summary>
	<brief_title>BAY63-2521 : Long-term Extension Study Patients With Pulmonary Arterial Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Familial Primary Pulmonary Hypertension</mesh_term>
	<mesh_term>Hypertension , Pulmonary</mesh_term>
	<criteria>Patients complete 12 week treatment double blind trial PATENT 1 Patients ongoing serious adverse event PATENT 1 assess related BAY632521 allow participate extension trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Pulmonary arterial hypertension</keyword>
	<keyword>PH</keyword>
	<keyword>Stimulator</keyword>
</DOC>